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Abstract The aim of the study was to evaluate visual and
brainstem auditory evoked potentials (VEP, BAEP) in
multiple sclerosis (MS) patients with regards to fatigue and
disease-related variables. The study comprised 86 MS
patients and 40 controls. Fatigue was assessed using the
Fatigue Severity Scale (FSS/FSS-5) and the Modified
Fatigue Impact Scale (MFIS). Latencies and amplitudes of
the P100 component of VEP and the I–V components of
BAEP were analyzed. The results of EP were compared
between non-fatigued, moderately and severely fatigued
MS patients and controls. P100 latency was increased and
amplitude decreased in moderately and severely fatigued
MS subjects. The latency of the V component of BAEP and
interlatencies I-III-V were increased in severely fatigued
patients. The amplitude of the V component was lowered
in fatigued patients. VEP and BAEP abnormalities were
usually one-sided. Interocular P100 latency difference
tended to correlate with FSS/FSS-5. The parameters of
VEP and BAEP correlated with functional system scores
but not with MS duration, overall degree of disability or its
progression over time. Significant, usually asymmetrical
VEP and BAEP abnormalities were found in fatigued MS
patients, with no relationships to disease-related variables.
EP may be considered an electrophysiological marker of
fatigue in MS patients.
Keywords Multiple sclerosis  Fatigue 
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Introduction
Fatigue is commonly reported by patients with multiple
sclerosis and has a profound impact upon their daily
activities and quality of life. Although often discussed in
recent years, the origin of fatigue remains unclear. Evalu-
ation of fatigue also brings about difficulties because of its
lack of the objective biomarkers [1, 2]. According to some
theories, the background of fatigue is associated with dis-
turbed bioelectrical neuronal activity due to demyelination
and axonal loss [3, 4]. Studies with the use of motor evoked
potentials and electroencephalography event-related de-
synchronization have indeed shown decreased neuronal
excitability and frequency-dependent conduction block in
fatigued MS patients [5–8]. Visual and auditory evoked
potentials are regarded as useful tools for recognizing and
monitoring damage to central nervous system ascending
pathways in the course of MS. However, these methods
have not been used so far in studies on MS fatigue,
investigating its origin and methods of its evaluation.
The aim of our study was to assess visual and brainstem
auditory evoked potentials (BAEP) in MS patients with
regard to the presence and severity of fatigue, considering
also the impact of other disease-related variables.
Materials and methods
The study comprised 86 patients with MS (24 men and 62
women, aged 19–60 years, mean 39.55) who were under the
care of the outpatient MS clinic, Department of Neurology,
Medical University of Wroclaw. All the patients met the
McDonald’s criteria [9] of clinically definite MS. None of
the patients had concomitant diseases known to cause fati-
gue or to affect parameters of visual and auditory evoked
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potentials in their history. 62 patients had never been treated
with disease-modifying agents. 24 subjects had undergone
treatment with interferon beta or glatiramer acetate for
1–3 years, but treatment had ceased at least 6 months prior
to their inclusion in this study (in 15 patients because of their
transition into secondary progressive phase of MS; nine
subjects resigned from the treatment due to its side effects or
for personal reasons). None of the patients were being
treated with chronic immune-suppression. A washout period
of at least 4 weeks was maintained between inclusion in the
study and tapering treatment with corticosteroids due to the
most recent MS relapse.
The control group consisted of 40 healthy volunteers,
who were matched for age and gender to the MS patients
(12 men, 28 women, aged 23–60 years, mean 38.8).
All the subjects gave their informed consent to partici-
pate in the study and the project was approved by the
Bioethical Committee at the Medical University of
Wroclaw.
The patients underwent a neurological examination and
their disability was assessed using the Expanded Disability
Status Scale (EDSS) [10], with visual and brainstem
functional systems (FS) scores separated for further ana-
lysis. On the basis of medical records, the duration of the
disease was defined and the index of disability progression
[Multiple Sclerosis Severity Scale (MSSS)] calculated
[11]; the history of optic neuritis or loss of hearing was also
determined.
Assessment of fatigue
The level of fatigue in MS patients was evaluated using
self-assessment questionnaires based on the Fatigue
Severity Scale (FSS) [12] and the Modified Fatigue Impact
Scale (MFIS) [13], with the results of FSS re-evaluated
using the Rasch analysis applied by Mills et al. [14] (FSS-
5). On the basis of FSS/FSS-5 results, the patients were
divided into three subgroups: without fatigue (subgroup I,
FSS/FSS-5 \3.5), with moderate (subgroup II, FSS/FSS-
5 = 3.5–5.5) or severe fatigue (subgroup III, FSS/FSS-5
[5.5).
Evoked potentials
Visual evoked potentials (VEP) were performed by using a
black and white checker board pattern on a screen, with a
checker size of 36 cm2 and the frequency of pattern
reversing being 1.9 Hz. The subjects were sitting in the
distance of 1 m from the screen, with the angle of vision
290. The stimuli were presented uni-ocularly. An active
recording electrode was attached to the scalp on the mid-
line at the occipital region (Oz according to the 10–20
system), the reference electrode was placed on the midline
frontal point (Fz) and the ground electrode on the forearm.
Ag/AgCl surface electrodes were used and their impedance
was maintained below 5 k Ohm. The responses were ana-
lyzed with a Nicolet 1000 Viking Quest, with a 1–30 Hz
bandpass filter and a sweep time of 500 ms. A hundred
responses were averaged in each run and two runs were
performed for each eye. For each subject, the latency and
amplitude (‘‘peak to peak’’) of the P100 component were
determined for each eye, as well as relative P100 latency
(interocular latency difference).
BAEP were performed with the use of stimuli presented
to each ear separately via earphones. Auditory stimuli were
clicks of a duration of 0.1 ms, frequency 20.3 Hz and an
intensity 65 dB higher than the hearing threshold initially
established for each subject. A recording electrode was
attached to the earlobe on the side of stimulation, with the
reference electrode placed on the vertex (Fz) and the
ground electrode on the forearm. Ag/AgCl surface elec-
trodes were used and their impedance was maintained
below 5 k Ohm. The responses were analyzed with a
Nicolet 1000 Viking Quest, with a 150–3,000 Hz bandpass
filter and a sweep time of 10 ms. Two hundred responses
were averaged in each run and two runs were performed for
each ear. Latencies and amplitudes (‘‘peak to peak’’) were
determined for components I, III and V, as well as inter-
peak latencies I–III, III–V, I–V and the proportion of
amplitudes I/V.
Statistical analysis
Mean and median values with standard deviations were
calculated for all the analyzed variables. The EP parame-
ters obtained from the whole group of MS patients and
subgroups I, II and III were compared with those from the
controls, and the results were also compared between
subgroups I, II and III with the use of post hoc test (Scheffe
test) and then analysis of variance (ANOVA), alternatively
using the Kruskal–Wallis test, when the variances in
groups were not homogeneous (the homogeneity of vari-
ance was determined by the Bartelett’s test) or if the
number of cases was too small. Relation between contin-
uous fatigue measures and continuous EP parameters was
assessed using correlation analysis and Pearson correlation
coefficients were calculated. Relation between continuous
fatigue measures and categorized parameters (visual FS,
brainstem FS) was assessed using correlation analysis and
Spearman correlation coefficients were calculated. Multi-
ple regression analysis was used to check the impact of age
and MS-related variables upon correlations between fati-
gue measures and EP results. p \ 0.05 was regarded as
statistically significant and p \ 0.07 sufficient to observe
trends. The statistical analysis was performed using EPI-
INFO ver. 3.5.2 software.
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Results
On the basis of FSS/FSS-5 results, 29 patients (8 men, 21
women) were allocated to subgroup I (non-fatigued), 31
patients (7 men, 24 women) to subgroup II (moderately
fatigued) and 26 (8 men, 18 women) to subgroup III
(severely fatigued). No significant differences in terms of
age or gender were found either between these groups, or
between each of them and the healthy controls.
The results of MFIS on the whole group of patients
ranged from 4 to 64 (mean 36.3). There was a significant
correlation between MFIS results and the age of the MS
patients (R = 0.24, p = 0.02). No such correlations were
found for FSS/FSS-5 results.
In MS patients the duration of the disease was
1–30 years (mean 8.57), EDSS 1–6.5 (mean 3.03) and
MSSS 1.1–8.8 (mean 4.4). Visual FS scores ranged from 0
to 3 (mean 0.8), and so did Brainstem FS scores (mean
1.2). 42 patients had a history of optic neuritis, while none
experienced loss of hearing during MS relapse. Patients
with or without the history of optic neuritis did not differ
significantly in the mean values of FSS/FSS-5 (4.63 vs
4.02, p = 0.1) or MFIS (39.1 vs 33.7, p = 0.12). FSS/FSS-
5 and MFIS correlated significantly with EDSS, visual and
brainstem FS (Table 1).
The mean duration of the disease was longer in sub-
group III in comparison with subgroup I (11.56 vs
5.38 years, p = 0.003). The mean EDSS score was higher
in subgroups II and III in comparison with subgroup I (2.98
vs 4.08 vs 2.12, p = 0.027 and 0.0000001, respectively).
The mean MSSS score was higher in subgroup III in
comparison with subgroups II and I (5.32 vs 4.16 vs 3.86,
p = 0.047 and 0.014, respectively).
The mean latency of the P100 component of VEP for
both eyes was significantly longer in MS patients than in
the controls, and so was the mean relative P100 latency
(interocular latency difference). The mean P100 amplitude
was significantly lower for MS patients than in controls,
but only for the left eye (Table 2).
P100 latency for the right eye was significantly longer in
subgroups II and III than in subgroup I, and relative P100
latency was significantly longer in subgroup III than in
subgroup I (Table 2). The amplitude of P100 for the left
eye was lower in subgroups II and III than in the controls,
and for the right eye—lower in subgroup III than in sub-
group I (Table 1). No significant correlations were found
between the summated values of VEP latency and ampli-
tude and FSS/FSS-5 or MFIS. The relative latency of P100
tended to correlate positively with FSS/FSS-5 (R = 0.26,
p = 0.07). There was a significant correlation between
summated VEP amplitude and Visual FS (R = -0.36,
p = 0.0006) and a correlation on the edge of significance
between summated VEP latency and Visual FS (R = 0.21,
p = 0.05). No correlations were found between VEP
parameters and other clinical MS-related variables (dura-
tion of the disease, EDSS or MSSS).
The mean latencies of I, III and V components of BAEP
on both sides did not differ significantly between MS
patients and controls. Mean interlatencies I–III on the left
side, III–V on the right side and I–V on both sides were
significantly longer in patients than in the controls. The
mean amplitude of the V component was significantly
lower in MS patients than in the controls, but only on the
right side (Table 3).
The latency of the V component of BAEP, and interla-
tency I–V for the left ear as well as interlatencies III–V and
I–V for the right ear were significantly longer in subgroup
III than in the controls. In subgroup II, the latency of the V
component and interlatencies III–V, and I–V for the right ear
were significantly longer than in the controls (Table 3). The
amplitude of the V component for the right ear was signif-
icantly lower in subgroups II and III than in the controls
(Table 3). No correlations were found between the BAEP
parameters (one-sided or summated values) and fatigue
measures (FSS/FSS-5, MFIS). Among the BAEP parame-
ters, interlatencies III–V and I–V showed significant positive
correlations with MSSS (III–V: R = 0.28, p = 0.009;
R = 0.25, p = 0.024; I–V: R = 0.25, p = 0.021; R = 0.2,
p = 0.05; for left and right side, respectively). Summated
latencies of BAEP components correlated significantly with
Brainstem FS (I: R = 0.23, p = 0.04; III: R = 0.23,
p = 0.03; V: R = 0.36, p = 0.0008) and so did summated
amplitude of V component (R = 0.23, p = 0.03). No other
correlations were found between BAEP parameters and
remaining clinical MS-related variables (duration of the
disease, EDSS or MSSS).
Discussion
The importance of evoked potentials (EP) in the diagnosis
of MS has decreased in the last decade as magnetic reso-
nance has become the main diagnostic tool supporting
clinical assessment. However, EP abnormalities are still
regarded as good electrophysiological markers of disease
progression and their prognostic value in the early stages of
Table 1 Correlations between fatigue measures (FSS/FSS-5, MFIS)
and degree of disability (EDSS, visual FS, brainstem FS); R Spear-
man’s correlation coefficient
EDSS Visual FS Brainstem FS
FSS/FSS-5 R = 0.48 R = 0.3 R = 0.26
p = 0.00001 p = 0.006 p = 0.018
MFIS R = 0.46 R = 0.32 R = 0.24
p = 0.0001 p = 0.003 p = 0.025
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MS gains increasing attention [15–17]. Non-invasiveness
and the availability of EP also encourage their use in
clinical practice. Fatigue constitutes an important aspect of
non-physical disability in MS patients, which is still lack-
ing objective biomarkers, so analysis of EP parameters
with regards to fatigue in MS seemed worth investigating.
We deliberately chose VEP and BAEP as they have not
been used in this field so far (in contrast to MEP).
Analysis of VEP showed significantly prolonged latency
of the P100 component in the whole group of MS patients
as well as in each of the three subgroups, when compared
to the controls. Such a finding is common in MS subjects
and indicates slowed conduction in the optic tract due to
demyelination. It is worth noting that only severely fati-
gued patients in comparison with non-fatigued ones
showed a significantly increased interocular latency dif-
ference (relative P100 latency). This parameter tended to
correlate (although not significantly) with one of the fati-
gue measures (FSS/FSS-5), but—apart from visual FS
score—did not show significant relationships with other
disease-related variables (duration of MS, EDSS or MSSS).
Although no correlation was found between relative P100
latency and the result of MFIS (which allows more detailed
assessment of fatigue than FSS), it might be interesting to
refer VEP results to physical and cognitive aspects of
fatigue. Significant differences in P100 amplitude were
also asymmetrical but they were found not only between
fatigued and non-fatigued subgroups but also between MS
patients and controls. The amplitude of VEP components is
usually regarded as a more variable and thus less sensitive
parameter than latency, so we believe P100 latency
deserves more attention in further investigation.
P100 latency is known to increase with age, especially in
men. Subgroups I, II and III did not differ significantly as
regards age and gender structure, so the influence of demo-
graphic factors upon VEP parameters can be neglected.
In the only available study comprising MS patients (i.e.,
Regan et al. [18]), VEP were used to evaluate the fatiga-
bility of the visual pathway. In those patients with MS and
glaucoma (but not in parkinsonic ones), the amplitude of
P100 increased when additional stimuli were superimposed
on the basic pattern of stimulation. Our results seem more
consistent with the report of Sobieszczan´ska et al. [19],
who assessed VEP as a measure of fatigability in healthy
persons, professionally operating computer terminals. After
a few hours of their constant gazing at the computer screen,
there was an increase in P100 latency, a decrease in
amplitude, and moreover, a decrease in correlation coeffi-
cients for the VEP parameters obtained from both hemi-
spheres. Overall, the abnormalities of VEP parameters in
our material can be attributed to the impact of MS in
general, but the asymmetry of these abnormalities might
have been more specific for fatigue.
Unlike the optic tract, the auditory pathway is much less
frequently affected by demyelination in the course of MS.
In the whole group of our MS patients in comparison with
the controls, we only found significantly prolonged inter-
latencies between I, III and V components of BAEP, which
indicate subtle conduction disturbances within the brain-
stem. On analysis of the subgroups of patients with and
without fatigue, these abnormalities appeared to occur only
in those with moderate and severe fatigue. It has to be
considered that these subgroups also presented with higher
level of disability and rate of its progression. The interla-
tencies of BAEP components indeed showed significant
correlations with MSSS but not with any of the fatigue
measures. Moreover, the fatigued patients also showed
prolonged latency of the V component of BAEP (while
non-fatigued ones and the whole MS group did not). This
parameter, in turn, did not correlate significantly with the
majority of disease-related variables, apart from Brainstem
FS. It is worth noting that significant findings in BAEP
parameters mostly concerned only one side.
To our knowledge, there have been no reports on BAEP
with regards to fatigue in MS patients. Neri et al. [20] and
Bianchedi et al. [21] described abnormalities of BAEP (the
lack of component I and prolonged interlatencies) in sub-
jects with chronic fatigue syndrome, which occurred only
at higher frequencies of auditory stimulation, so were
apparently revealed at a greater burden to the auditory
pathway.
The relationship between fatigue and other symptoms and
signs of neurological deficit remains a disputable matter [1,
2]. In our study, fatigue measures showed significant corre-
lations with EDSS (general degree of disability, although
mostly determined by ambulation skills) as well as with
visual and brainstem FS scores. Fatigue is a complex phe-
nomenon, not limited to incapability of physical effort due to
motor deficit, but also possibly associated with dysfunction
of other systems. Thus, VEP and BAEP, as sensitive and
objective markers of visual and brainstem pathways (their
parameters correlated significantly with corresponding FS
scores), might provide measures of other aspects of disability
contributing to fatigue.
The asymmetry of EP abnormalities in our study seemed
more specifically associated with fatigue than with MS
itself. Asymmetrical damage to CNS pathways interferes
with the perception and integration of stimuli of particular
modality. To compensate for these dysfunctions, some
additional areas of the brain may become activated. This
corresponds with the concept of fatigue as a result of
excessive load of CNS due to dysfunction of specific areas,
as is supported by neuroimaging studies involving MS
patients with fatigue [3, 22, 23].
To the best of our knowledge, so far there has been no
report investigating visual and auditory EP with regards to
Neurol Sci (2015) 36:235–242 241
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fatigue in a large and well-defined group of MS patients.
Abnormalities of EP in fatigued patients, independent from
MS-related variables, may support the hypothesis of dis-
turbed bioelectrical activity due to CNS damage as the
background of fatigue, which contradicts the idea of its
purely subjective origin. EP parameters seem promising as
possible electrophysiological markers of fatigue with the
asymmetry of their abnormalities deserving special atten-
tion. A limitation of our study is the fact that the assess-
ment of fatigue and EP parameters was performed only
once, without re-testing to check for reliability of the
results. Considering the common fluctuations of MS
symptoms and the variability of EP parameters, we have
already planned further study including parallel monitoring
of fatigue and EP in the course of the disease to evaluate
their relationships in prospective observation.
In conclusion, the parameters of VEP and BAEP
undergo significant, mostly asymmetrical changes in MS
patients with moderate and severe fatigue. These findings
seem to support the hypothesis of neuronal pathways
dysfunction as the background of MS fatigue. The role of
EP parameters as electrophysiological markers of fatigue
seems promising and deserves further investigation.
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